Daniel P Morin, Elizabeth S Kaufman, Kristen Bova Campbell, Andrew E Epstein, Zachary D Goldberger, Bülent Görenek, Jeroen M L Hendriks, Prince J Kannankeril, Kamala P Tamirisa, Santiago O Valdés, Emily P Zeitler, Naga Venkata K Pothineni, (Scientific Documents Committee Liaison)
Antiarrhythmic drugs can be an important treatment option for patients with heart rhythm disorders, but not all patients and scenarios are represented in trials related to antiarrhythmic drug use. This Heart Rhythm Society scientific statement identifies common clinical scenarios for which little guidance exists, at least partly because they are understudied. It also provides as much practical advice as possible, sourcing available evidence and the clinical proficiency of a diverse group of experienced clinicians, and provides the rationale for each recommendation.